Joanne Waldstreicher
CIK: 0001962413
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 17, 2026GPCR
Structure Therapeutics Inc.
Award(A)DirectShare Option (right to buy)
39.5K shares- - Jan 27, 2026BDX
BECTON DICKINSON & CO
Award(A)Direct1.1K shares- - Jun 23, 2025GPCR
Structure Therapeutics Inc.
Award(A)DirectShare Option (right to buy)
51.8K shares- - Jan 28, 2025BDX
BECTON DICKINSON & CO
Award(A)Direct930 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  GPCR Structure Therapeutics Inc. | Award(A) Share Option (right to buy) | 39,453 | - | - | Direct |
| Jan 27, 2026 |  BDX BECTON DICKINSON & CO | Award(A) | 1,098 | - | $0 | Direct |
| Jun 23, 2025 | GPCR Structure Therapeutics Inc. | Award(A) Share Option (right to buy) | 51,804 | - | - | Direct |
| Jan 28, 2025 | BDX BECTON DICKINSON & CO | Award(A) | 930 | - | $0 | Direct |
1-4 of 4 transactions
About Waldstreicher Joanne
Waldstreicher Joanne (SEC CIK 0001962413) files insider reports with the SEC as Director of Structure Therapeutics Inc. (GPCR) and Director of BECTON DICKINSON & CO (BDX).
Signal8 holds 4 ownership filings by Waldstreicher Joanne, all Form 4s, filed between Jan 30, 2025 and Jun 18, 2026. Those filings report 4 transactions, from Jan 28, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Waldstreicher Joanne's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Waldstreicher Joanne
Other insiders filing for Structure Therapeutics Inc. (GPCR)
- Coll Crespo Blas, CHIEF MEDICAL OFFICER
- Lin Xichen, CHIEF SCIENTIFIC OFFICER
- Berrios John Joseph, Chief Commercial Officer
- FMR LLC, 10% Owner
- Russell Angus C., Director
- LOVE TED W, Director